More than 83.86 million Qualcomm Inc. (NASDAQ: QCOM) shares were sold short as of the most recent settlement date. That represented 5.7% of the chipmaker’s float and was a retreat of nearly 8% from in the prior period, but still much more than the fewer than 30 million shares seen back in August. As of the middle of this month, it would take less than five days for investors to cover all their short positions at the posted average daily volume.
Qualcomm received at least one analyst upgrade during the short interest period. However, the November 15 closing share price was almost 13% lower than on the previous settlement date. It has climbed less than 2% in the past week, and the stock was last seen trading at $55.57 a share, down from the 52-week high of $76.50. The 52-week low is $48.56 per share. And the share price is more than 17% lower than it was 90 days ago.
Comcast Corp.’s (NASDAQ: CMCSA) short interest increased by more than 8% in the latest period to the second highest level since May. The more than 72.22 million shares on the most recent settlement date represented 1.6% of the total float. The year-to-date high was more than 86 million shares short back in January. Also note that the latest days to cover figure was up to more three as the average daily volume shrank handily.
Barclays reinstated coverage of Comcast during the period, despite presidential tweets. Comcast’s share price ended the latest two-week period marginally higher, after being down more than 2% earlier in the short interest period. The stock closed most recently at $38.36 per share, which is up 5% or so from 90 days ago. Shares have changed hands at between $30.43 and $44.00 apiece in the past year.
Almost 69.07 million TherapeuticsMD Inc. (NASDAQ: TXMD) shares were sold short as of the most recent settlement date. That represented 36.2% of the women’s health care company’s float, and it was less than 1% fewer than in the prior period, which was a year-to-date high level of short interest. As of the settlement date, it would take more than 21 days for investors to cover all their short positions, after the average daily volume slipped marginally.
This month, TherapeuticsMD posted a smaller-than-expected net loss for its most recent quarter. The November 15 closing share price was more than 5% higher than on the previous settlement date, after bouncing as high as about 6% and as low as -4% or so earlier in the period. The stock closed most recently at $4.85 a share, which is more than 21% lower than 90 days ago. Shares have traded hands at between $4.30 and $7.66 apiece in the past 52 weeks.
Rounding out the top 10 were Opko Health Inc. (NASDAQ: OPK), Starbucks Corp. (NASDAQ: SBUX), Intel Corp. (NASDAQ: INTC) and Mattel Inc. (NASDAQ: MAT). Intel and Mattel returned to the top 10 as of the latest settlement date, the former with about a 12% pop in the number of its shares short. Meanwhile, the short interest at Starbuck fell almost 20% in the period.
Lingering outside the spotlight of the top 10 most shorted Nasdaq stocks were Zynga Inc. (NASDAQ: ZNGA), Novavax Inc. (NASDAQ: NVAX) and Helios and Matheson Analytics Inc. (NASDAQ: HMNY). The parent of MoviePass slipped out of the top 10 with a 37% plunge in its short interest.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.